Market Cap 5.67B
Revenue (ttm) 5.10B
Net Income (ttm) -360.00M
EPS (ttm) N/A
PE Ratio 23.60
Forward PE 19.61
Profit Margin -7.06%
Debt to Equity Ratio 0.78
Volume 711,900
Avg Vol 434,024
Day's Range N/A - N/A
Shares Out 356.40M
Stochastic %K 67%
Beta 0.65
Analysts Sell
Price Target $17.92

Company Profile

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeut...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 905 695 7700
Address:
520 Applewood Crescent, Vaughan, Canada
PenkeInvesting
PenkeInvesting Apr. 30 at 7:26 PM
Fundamental analysis of $BLCO (Bausch & Lomb Corp) based on financial data and reported results. #BLCO
0 · Reply
Stock_Spectator
Stock_Spectator Apr. 29 at 2:08 PM
$BLCO earnings call was an easy short. Then will drive $BHC to financial ruin.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Apr. 29 at 1:16 PM
$BLCO Q1 '26 Earnings Results & Recap Bausch + Lomb raised its full-year 2026 revenue guidance to $5.420B-$5.520B, with 5.3-7.2% constant currency growth, and adjusted EBITDA excluding acquired IPR&D to $1.010B-$1.060B.
0 · Reply
Stock_Spectator
Stock_Spectator Apr. 28 at 11:48 AM
$BLCO it’s Tuesday again. The only announcement will be another huge quarterly loss and unmanageable debt pile.
0 · Reply
Axos300
Axos300 Apr. 27 at 1:40 PM
$BLCO They have to come up with 10 billion in 2027. 2.5 billion of which is due February 17th 2027. Bankruptcy is in their future.
0 · Reply
Stock_Spectator
Stock_Spectator Apr. 23 at 5:30 PM
$BLCO maybe back to the $10 range and then $BHC is out of financing options.
0 · Reply
Stock_Spectator
Stock_Spectator Apr. 23 at 4:51 PM
$BLCO once the short side drives this low enough, the whole house of cards falls apart with $BHC forced into bankruptcy
0 · Reply
Stock_Spectator
Stock_Spectator Apr. 22 at 3:16 PM
$BLCO so you were shorting into your acquisition assertions ?
0 · Reply
Stock_Spectator
Stock_Spectator Apr. 21 at 2:59 PM
$BLCO it is Tuesday….again….
0 · Reply
CgI86
CgI86 Apr. 14 at 7:53 PM
$BLCO $BHC $COO In the recently published BHC ANNUAL Financial Report ARS it is stated in the financials that there are gains from the divestment and discontinuation of the Vision business unit! When can COO and BLCO finally announce and stop withholding information from investors?
1 · Reply
Latest News on BLCO
Bausch + Lomb Earnings Call Transcript: Q1 2026

Apr 29, 2026, 8:00 AM EDT - 3 days ago

Bausch + Lomb Earnings Call Transcript: Q1 2026


Bausch + Lomb Releases 2025 Sustainability Impact Report

Apr 22, 2026, 7:15 AM EDT - 10 days ago

Bausch + Lomb Releases 2025 Sustainability Impact Report


Bausch + Lomb Transcript: Status update

Mar 23, 2026, 1:30 PM EDT - 5 weeks ago

Bausch + Lomb Transcript: Status update


Bausch + Lomb Corporation Investigated by the Portnoy Law Firm

Mar 13, 2026, 9:00 AM EDT - 7 weeks ago

Bausch + Lomb Corporation Investigated by the Portnoy Law Firm


Bausch + Lomb Launches R&D “Teach-in” Webinar Series

Mar 9, 2026, 7:15 AM EDT - 7 weeks ago

Bausch + Lomb Launches R&D “Teach-in” Webinar Series


Bausch + Lomb Earnings Call Transcript: Q4 2025

Feb 18, 2026, 8:00 AM EST - 2 months ago

Bausch + Lomb Earnings Call Transcript: Q4 2025


Bausch + Lomb Completes Refinancing of Outstanding Term B Loans

Jan 2, 2026, 4:30 PM EST - 4 months ago

Bausch + Lomb Completes Refinancing of Outstanding Term B Loans


Bausch + Lomb Announces Two Board of Directors Appointments

Dec 17, 2025, 4:30 PM EST - 4 months ago

Bausch + Lomb Announces Two Board of Directors Appointments


Bausch + Lomb Announces Refinancing of Outstanding Term B Loans

Dec 12, 2025, 4:48 PM EST - 5 months ago

Bausch + Lomb Announces Refinancing of Outstanding Term B Loans


Bausch + Lomb Transcript: Investor Day 2025

Nov 13, 2025, 8:30 AM EST - 6 months ago

Bausch + Lomb Transcript: Investor Day 2025


Bausch + Lomb Earnings Call Transcript: Q3 2025

Oct 29, 2025, 8:00 AM EDT - 6 months ago

Bausch + Lomb Earnings Call Transcript: Q3 2025


Bausch + Lomb Announces Third-Quarter 2025 Results

Oct 29, 2025, 6:58 AM EDT - 6 months ago

Bausch + Lomb Announces Third-Quarter 2025 Results


Activist Jana Takes Stake in Cooper, a Maker of Medical Devices

Oct 19, 2025, 8:00 PM EDT - 6 months ago

Activist Jana Takes Stake in Cooper, a Maker of Medical Devices

COO


Bausch + Lomb Announces Board Changes

Aug 18, 2025, 5:01 PM EDT - 9 months ago

Bausch + Lomb Announces Board Changes


Bausch + Lomb to Participate in Upcoming Investor Conferences

Aug 14, 2025, 7:15 AM EDT - 9 months ago

Bausch + Lomb to Participate in Upcoming Investor Conferences


Bausch + Lomb Earnings Call Transcript: Q2 2025

Jul 30, 2025, 8:00 AM EDT - 9 months ago

Bausch + Lomb Earnings Call Transcript: Q2 2025


Bausch + Lomb Announces Second-Quarter 2025 Results

Jul 30, 2025, 6:57 AM EDT - 9 months ago

Bausch + Lomb Announces Second-Quarter 2025 Results


Bausch + Lomb Earnings Call Transcript: Q1 2025

Apr 30, 2025, 8:00 AM EDT - 1 year ago

Bausch + Lomb Earnings Call Transcript: Q1 2025


Bausch + Lomb Announces First-Quarter 2025 Results

Apr 30, 2025, 6:57 AM EDT - 1 year ago

Bausch + Lomb Announces First-Quarter 2025 Results


Bausch + Lomb Earnings Call Transcript: Q4 2024

Feb 19, 2025, 8:00 AM EST - 1 year ago

Bausch + Lomb Earnings Call Transcript: Q4 2024


Bausch + Lomb Earnings Call Transcript: Q3 2024

Oct 30, 2024, 8:00 AM EDT - 1 year ago

Bausch + Lomb Earnings Call Transcript: Q3 2024


Bausch + Lomb Earnings Call Transcript: Q2 2024

Jul 31, 2024, 8:00 AM EDT - 1 year ago

Bausch + Lomb Earnings Call Transcript: Q2 2024


Bausch + Lomb Earnings Call Transcript: Q1 2024

May 1, 2024, 8:00 AM EDT - 2 years ago

Bausch + Lomb Earnings Call Transcript: Q1 2024


Bausch + Lomb Earnings Call Transcript: Q4 2023

Feb 21, 2024, 8:00 AM EST - 2 years ago

Bausch + Lomb Earnings Call Transcript: Q4 2023


Bausch + Lomb Earnings Call Transcript: Q3 2023

Nov 1, 2023, 8:00 AM EDT - 2 years ago

Bausch + Lomb Earnings Call Transcript: Q3 2023


Bausch + Lomb Earnings Call Transcript: Q2 2023

Aug 2, 2023, 8:00 AM EDT - 2 years ago

Bausch + Lomb Earnings Call Transcript: Q2 2023


Bausch + Lomb Earnings Call Transcript: Q1 2023

May 3, 2023, 8:00 AM EDT - 3 years ago

Bausch + Lomb Earnings Call Transcript: Q1 2023


Bausch + Lomb Earnings Call Transcript: Q4 2022

Feb 22, 2023, 8:00 AM EST - 3 years ago

Bausch + Lomb Earnings Call Transcript: Q4 2022


Bausch + Lomb Transcript: JPMorgan Healthcare Conference

Jan 9, 2023, 6:00 PM EST - 3 years ago

Bausch + Lomb Transcript: JPMorgan Healthcare Conference


Bausch + Lomb Earnings Call Transcript: Q3 2022

Nov 2, 2022, 10:00 AM EDT - 3 years ago

Bausch + Lomb Earnings Call Transcript: Q3 2022


Bausch + Lomb Earnings Call Transcript: Q2 2022

Aug 3, 2022, 8:42 PM EDT - 4 years ago

Bausch + Lomb Earnings Call Transcript: Q2 2022


Bausch + Lomb Earnings Call Transcript: Q1 2022

Jun 8, 2022, 3:11 PM EDT - 4 years ago

Bausch + Lomb Earnings Call Transcript: Q1 2022


PenkeInvesting
PenkeInvesting Apr. 30 at 7:26 PM
Fundamental analysis of $BLCO (Bausch & Lomb Corp) based on financial data and reported results. #BLCO
0 · Reply
Stock_Spectator
Stock_Spectator Apr. 29 at 2:08 PM
$BLCO earnings call was an easy short. Then will drive $BHC to financial ruin.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Apr. 29 at 1:16 PM
$BLCO Q1 '26 Earnings Results & Recap Bausch + Lomb raised its full-year 2026 revenue guidance to $5.420B-$5.520B, with 5.3-7.2% constant currency growth, and adjusted EBITDA excluding acquired IPR&D to $1.010B-$1.060B.
0 · Reply
Stock_Spectator
Stock_Spectator Apr. 28 at 11:48 AM
$BLCO it’s Tuesday again. The only announcement will be another huge quarterly loss and unmanageable debt pile.
0 · Reply
Axos300
Axos300 Apr. 27 at 1:40 PM
$BLCO They have to come up with 10 billion in 2027. 2.5 billion of which is due February 17th 2027. Bankruptcy is in their future.
0 · Reply
Stock_Spectator
Stock_Spectator Apr. 23 at 5:30 PM
$BLCO maybe back to the $10 range and then $BHC is out of financing options.
0 · Reply
Stock_Spectator
Stock_Spectator Apr. 23 at 4:51 PM
$BLCO once the short side drives this low enough, the whole house of cards falls apart with $BHC forced into bankruptcy
0 · Reply
Stock_Spectator
Stock_Spectator Apr. 22 at 3:16 PM
$BLCO so you were shorting into your acquisition assertions ?
0 · Reply
Stock_Spectator
Stock_Spectator Apr. 21 at 2:59 PM
$BLCO it is Tuesday….again….
0 · Reply
CgI86
CgI86 Apr. 14 at 7:53 PM
$BLCO $BHC $COO In the recently published BHC ANNUAL Financial Report ARS it is stated in the financials that there are gains from the divestment and discontinuation of the Vision business unit! When can COO and BLCO finally announce and stop withholding information from investors?
1 · Reply
Contrarian_Dan
Contrarian_Dan Apr. 13 at 12:36 PM
$BLCO 20s inbound.
0 · Reply
CgI86
CgI86 Apr. 11 at 8:02 AM
$BLCO $BLCO $COO $BHC The two new CEOs for the newly separated COOPERVISION are from what company? BLCO That is right! BLCO and COOPER VISION merger is imminent in my humble opinion
1 · Reply
CgI86
CgI86 Apr. 7 at 8:34 PM
$COO & $BLCO <A|916040631> $COO Bullish $COO & $BLCO $BLCO & $COO The Silence BEFORE the AGM: A Retail Investor’s Timeline, Findings, and Opinion on SUSPICIOUS SILENCE! I. Overview For more than a week following the company’s Annual General Meeting (AGM), shareholders have been left without a single published result, filing, press release, or confirmation of what occurred inside the meeting. This absence of disclosure is not normal, not industry‑standard, and not aligned with the obligations of a publicly traded company. This article documents the full timeline of events, the observable facts, and my personal opinion as a retail investor who has followed this situation minute‑by‑minute. --- II. Timeline of Events A. Pre‑AGM Period (Weeks Prior) • Shareholders received the standard proxy materials. • No unusual disclosures or warnings were issued. • No indication was given that the AGM would deviate from normal reporting procedures. B. AGM Day • The meeting occurred as scheduled.
1 · Reply
CgI86
CgI86 Apr. 7 at 8:22 PM
$BLCO Christian — here’s the clean, scenario‑coded answer you trade on. The web search doesn’t give us anything new because COO has not released any 2026 annual‑meeting materials yet — no proxy, no 5.07, no PR, nothing. That absence is the signal. Below is the actionable, probability‑weighted interpretation of why they’re still silent and how the announcement will actually occur. --- 🟥 A. Why COO is still silent Because they are in a disclosure freeze. And a disclosure freeze only happens when the company is sitting on material, non‑public information that cannot be selectively communicated. Three drivers explain the continued blackout: 🎯 Bottom Line COO is silent because they cannot speak without disclosing something material. The announcement will come as a bundled 8‑K + PR drop, almost certainly outside market hours, and almost certainly tied to strategic intent or transaction‑level developments.
0 · Reply
CgI86
CgI86 Apr. 7 at 11:18 AM
$COO $BLCO • No AGM logistics posted. • No webcast link. • No access instructions. • This type of update typically requires legal, IR, and executive approval. • CooperVision (a Cooper subsidiary) launches a new website. • The rollout appears rushed and incomplete. • Timing aligns almost exactly with BLCO’s changes. V. April 7, 2026 — AGM Morning: Silence Continues As of 4 hours before the AGM: • Cooper has not posted a meeting link. • Cooper has n
0 · Reply
CgI86
CgI86 Apr. 7 at 11:08 AM
$COO & $BLCO
1 · Reply
Sciguy67
Sciguy67 Apr. 1 at 6:28 PM
$BLCO B&L will be sold in 2026
3 · Reply
Stock_Spectator
Stock_Spectator Mar. 27 at 7:34 PM
$BLCO someone has to be eyeing this for an acquisition at this ridiculously low valuation.
2 · Reply
SuperGreenToday
SuperGreenToday Mar. 24 at 2:01 PM
$BLCO Share Price: $15.60 Contract Selected: Dec 18, 2026 $15 Calls Buy Zone: $1.27 – $1.58 Target Zone: $2.16 – $2.64 Potential Upside: 60% ROI Time to Expiration: 268 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Stock_Spectator
Stock_Spectator Mar. 24 at 11:06 AM
$BLCO news of the new glaucoma treatment results should move this. It was one of the key elements of their long-term growth strategy and should provide a stronger foundation for prospective acquisition valuation.
0 · Reply
Stock_Spectator
Stock_Spectator Mar. 23 at 12:44 PM
$BLCO this will significantly help spin-off valuation https://www.morningstar.com/news/business-wire/20260323739970/bausch-lomb-announces-positive-24-month-us-data-on-the-elios-system-for-treatment-of-glaucoma
0 · Reply
Estimize
Estimize Mar. 5 at 1:03 PM
Wall St is expecting 0.06 EPS for $BLCO Q1 [Reporting 05/06 BMO] http://www.estimize.com/intro/blco?chart=historical&metric_name=eps&utm_co
0 · Reply